Blueberry Therapeutics have unique nanopolymer drug delivery technology which opens up huge opportunities to rapidly develop new medicines and helps us find ways to treat dermatological disorders.
Latest News
Dermatology
Blueberry is committed to the development of innovative new therapies for the treatment of common dermatological disorders.
Nanomedicine
We use cutting-edge nano polymer drug delivery technology to exploit both small molecule and biologic approaches to developing treatments.
News
CSO David Cook presenting at Alderley Park Science Seminar series
Blueberry's CSO, Dr David Cook has been invited to present at the Alderley Park Science Seminar series with his talk [...]
What is the true burden of nail infections on patients’ well-being?
Written by Emma Leigh, Medical Writing Lead. Blueberry Therapeutics hopes to make a real difference to the quality of [...]
A Blueberry case study
In this video, CEO John Ridden and CSO David Cook talk about the early days of Blueberry Therapeutics, the short term and long term plans for the company, and the benefits of being based at Alderley Park, Cheshire.